Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Web Exclusives

Evolving Cancer Care in the Time of COVID-19
Web Exclusives — February 23, 2021
The need to protect patients and healthcare workers from contracting COVID-19 has resulted in many changes to how hospital care is delivered. Read More ›

Retrospective Analysis Suggests Higher Risk of Secondary Cancers with BTK Inhibitors in CLL
Web Exclusives — February 23, 2021
Recent data suggest that patients with CLL who received treatment with a BTK inhibitor had a rate of developing a second cancer over twice as high as that expected in the general population. Read More ›

Coronavirus Vaccines and People with Cancer: A Q&A with Dr. Steven Pergam

How Patients with Cancer Can Find Companionship During COVID-19
The social isolation of the COVID-19 pandemic has left those with cancer feeling more left out than ever. Finding companionship and building close relationships, whether in person or virtually, is essential to overall well-being. Read More ›

CONQUER Celebrates World Cancer Day
On World Cancer Day and every day, CONQUER magazine is dedicated to amplifying the voices of patients with cancer, survivors, caregivers, oncology care teams, and all those involved in the fight against cancer. Read More ›

Expanded Options for Treating Chronic Lymphocytic Leukemia
Targeted therapies continue to change the treatment landscape, improving outcomes beyond traditional chemoimmunotherapy. Read More ›

Costs of Healthcare Plans Projected to Continue Increasing in 2021
Although most employers are not passing costs to employees, the COVID-19 pandemic has raised uncertainty throughout the entire healthcare system. Read More ›

Low Risk of Cardiac Side Effects with Acalabrutinib for Chronic Lymphocytic Leukemia
An analysis of 4 studies finds that acalabrutinib does not increase the risk of developing heart problems for patients with CLL. Read More ›

Venetoclax Provides Long-Term Efficacy for Patients with Chronic Lymphocytic Leukemia
A 5-year analysis of the MURANO study shows patients completing venetoclax treatment have long-term, durable responses. Read More ›

First Estimates of Health Outcomes for Patients with Hematologic Cancers and COVID-19
A systematic review of publications finds that patients with hematologic cancers who contract COVID-19 have an increased risk of death. Read More ›

Page 9 of 25